Major investors in Diageo, the FTSE 100 spirits giant behind Guinness and Johnnie Walker, have voiced growing concern over the board’s inability to appoint a permanent chief executive, particularly after a recent profit warning drove shares to their lowest levels in a decade. The company passed its annual general meeting and issued a trading update this week without naming a successor to Debra Crew, who departed in July amid performance pressures. According to the Financial Times, the board has explored external contenders, including outgoing GSK chief executive Dame Emma Walmsley, despite interim leader Nik Jhangiani remaining the favored internal choice among many shareholders.
Jhangiani, who assumed the interim role after serving as chief financial officer since September 2024, indicated in August that a permanent appointment would occur by the end of October. His popularity stems from a strong track record at Coca-Cola Europacific Partners and investor-friendly communication, bolstered by an £8.5 million share award overwhelmingly approved at the AGM despite proxy adviser opposition. As reported by Reuters, one major holder noted that no superior alternative has emerged, while the award provides strong alignment with performance.
Yet internal tensions have complicated matters. Senior executives reportedly raised issues with chair Sir John Manzoni regarding Crew’s abrupt exit, potentially delaying proceedings and leaving strategic initiatives on hold pending a new leader’s vision. Diageo firmly rejected claims of board representations from management, insisting on a thorough process evaluating global internal and external talent. A spokesperson emphasized progress and promised market updates soon. As detailed in Invezz, the uncertainty has stalled key decisions, exacerbating challenges in a tough trading environment.
Walmsley, set to leave GSK at the year’s end after over eight years, was briefly a Diageo non-executive director in 2016. Sources close to GSK stressed that she has held no discussions and harbors no interest in the role. Current GSK finance chief Julie Brown sits on Diageo’s board, adding to speculation. Walmsley’s consumer health expertise at GSK and prior tenure at L’Oréal make her a notable figure, though her departure from the pharmaceutical firm follows a period of transformation. According to The Economic Times, such external considerations reflect broader efforts to refresh leadership amid sector headwinds.
The leadership limbo coincides with deteriorating market conditions. On 6 November, Diageo downgraded its full-year outlook, anticipating flat to slightly declining organic sales and only low-to-mid single-digit operating profit growth for fiscal 2026, citing softer US consumer spending and sharp declines in China. First-quarter organic net sales remained flat, with volumes up 2.9 percent but offset by negative pricing. Shares have tumbled 32 percent year-to-date, closing around £17.26 post-warning, prompting takeover vulnerability warnings. As noted by Reuters, analysts highlight exposure to premium brands in reversing industry dynamics.
Jhangiani has prioritized cost controls, raising savings targets to $625 million over three years and exploring asset disposals to trim $22 billion in debt. Potential tariffs on imports add further pressure, estimated at $200 million annually. Investors like Kai Lehmann at Flossbach von Storch demand a swift resolution for clarity, while Ninety One’s Ben Needham flagged heightened predation risks given iconic assets. As reported by This is Money, the slump has fueled speculation of bids, contrasting Diageo’s once-resilient premium positioning.
Diageo’s woes mirror broader spirits sector struggles, including post-pandemic demand normalization, shifting habits, and geopolitical uncertainties. Rivals like Pernod Ricard face similar pressures, but Diageo’s scale amplifies scrutiny. Jhangiani, of Indian origin with decades in finance across continents, brings operational credibility from prior roles at Bharti Enterprises and Coca-Cola. As profiled in Hindustan Times, his appointment as interim followed Crew’s mutual departure after investor confidence waned.
With no announcement imminent, pressure mounts on the board to resolve the succession promptly. Analysts anticipate limited immediate earnings shifts but stress that leadership stability is crucial for recovery. This episode underscores governance challenges at a company long prized for consistency, now navigating its most turbulent phase in years amid calls for decisive action to restore momentum and shareholder trust.